Clinical Trials on Postmenopausal Osteoporoses

Total 1807 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Bioequivalence of Two New Formulations of Premarin/MPA With Premarin/MPA Reference Formulation.

Postmenopause | Postmenopausal Osteoporosis
Nycomed

Completed

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Osteoporosis | Postmenopause

Germany
Fujian Academy of Traditional Chinese Medicine

Unknown

Clinical Study on Treatment of Postmenopausal Osteoporosis (Kidney Deficiency and Blood Stasis Syndrome) With Xulin Jiangu Granules (CSOPOPWXJG)

Postmenopausal Osteoporoses

China
National Center for Complementary and Integrative...

Completed

Effects of Black Cohosh on Menopausal Hot Flashes

Hot Flashes | Osteoporosis, Postmenopausal | Postmenopause

United States
Amgen

Completed

Efficacy, Safety and Tolerability of Romosozumab in the Treatment of Japanese Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis (PMO)

Japan
Deltanoid Pharmaceuticals

Completed

Safety Study of an Oral Vitamin D Analog in Postmenopausal Women

Postmenopausal Osteoporosis, Multiple Sites
Riphah International University

Completed

High Intensity Multi-Modal Exercise Training in Postmenopausal Women (HIT-MMEX)

Postmenopausal Osteoporosis | Postmenopausal Osteopenia

Pakistan
Amgen

Completed

Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis (FRAME)

Postmenopausal Osteoporosis

United States, Canada, Denmark, Germany, Belgium, Colombia, Czechia, Japan, Mexico, Poland, Switzerland, Hungary, Spain, Australia, Romania, United Kingdom, India, Argentina, Brazil, Dominican Republic, Estonia, Latvia, Lithuania, New...
Organon and Co

Completed

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Osteoporosis Postmenopausal
Penn State University
California Dried Plum Board

Active, not recruiting

Dried Plums and Bone Health in Postmenopausal Women

Postmenopausal Osteoporosis

United States
Massachusetts General Hospital
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Completed

Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration

Postmenopausal Osteoporosis

United States
Sahlgrenska University Hospital, Sweden
BioGaia AB

Completed

Prevention of Early Postmenopausal Bone Loss With Lactobacillus Reuteri (ELBOWII)

Postmenopausal Osteoporosis

Sweden
Samsung Bioepis Co., Ltd.

Completed

A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

Poland
Nigde Omer Halisdemir University

Completed

Efficacy of Denosumab Treatment in Bisphosphonate Unresponsive Patients

Postmenopausal Osteoporosis

Turkey
Amgen

Completed

A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis

Postmenopausal Osteoporosis

Korea, Republic of
Second Affiliated Hospital of Soochow University

Unknown

The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) (PMOP)

Postmenopausal Osteoporosis

China
Chiesi Farmaceutici S.p.A.

Completed

Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Italy
Novartis Pharmaceuticals

Completed

A Trial Evaluating the Effects of Zoledronic Acid 5 mg Infusion on Bone Mineral Density (BMD) in Postmenopausal Osteoporosis (PMO) Patients Between the Ages of 50 and 65 Years

Postmenopausal Osteoporosis

Turkey
Hoffmann-La Roche

Completed

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Germany
Merck Sharp & Dohme LLC

Withdrawn

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Alendronate (MK-0822-050)

Osteoporosis | Postmenopausal Osteoporosis
Eisai Co., Ltd.

Completed

Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women

Postmenopausal Osteoporosis

China
Warner Chilcott
Sanofi

Completed

Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate

Postmenopausal Osteoporosis

United States, Canada
Unigene Laboratories Inc.
GlaxoSmithKline

Completed

Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women

Postmenopausal Osteoporosis

Denmark, Estonia
Amgen

Completed

A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

Postmenopausal Osteoporosis
Warner Chilcott
Sanofi

Completed

Study to Assess BMD and Bone Turnover Response to 5 mg Daily Risedronate Treatment in Women With PMO

Postmenopausal Osteoporosis

Australia, Italy, Poland, Spain, Sweden
Novartis

Completed

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effect of PTH134 at Increasing Doses in Healthy Postmenopausal Subjects

Postmenopausal Osteoporosis

Switzerland
Eli Lilly and Company

Completed

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

United States
Novartis

Completed

Pharmacokinetics and Pharmacodynamics Study of Oral Salmon Calcitonin in Healthy Postmenopausal Women

Postmenopausal Osteoporosis

Denmark
Hoffmann-La Roche

Completed

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Postmenopausal Osteoporosis

United States
University of Chicago
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Texture Analysis for Postmenopausal Osteoporosis

Osteoporosis | Osteopenia

United States
Appalachian State University
North Carolina Agriculture & Technical State University

Completed

Moringa Oleifera on Bone Density

Postmenopausal Osteoporosis | Osteoporosis, Osteopenia

United States
Hoffmann-La Roche

Completed

Study of Post Menopausal Osteoporosis (PMO) Among Gynecology Outpatients in Pakistan

Postmenopausal Osteoporosis

Pakistan
Hoffmann-La Roche

Completed

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

Postmenopausal Osteoporosis

Belgium, Luxembourg, Austria, Greece, Ireland
Hoffmann-La Roche

No longer available

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Postmenopausal Osteoporosis

Taiwan
Hoffmann-La Roche

Completed

A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Postmenopausal Osteoporosis

Poland, Slovakia, Hungary, Russian Federation, Latvia, Romania, Slovenia
Dong-A ST Co., Ltd.

Recruiting

Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Postmenopausal Osteoporosis

Korea, Republic of
Chugai Pharmaceutical

Not yet recruiting

Post-Marketing Drug Intensive Monitoring Surveillance of EDIROL in Patients With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

China
Enzene Biosciences Ltd.
Alkem Laboratories Ltd

Recruiting

A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

Postmenopausal Osteoporosis

Czechia
Shanghai JMT-Bio Inc.

Recruiting

Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

China
Shanghai Hansoh Biomedical Co., Ltd

Recruiting

Comparing of the Pharmacokinetic, Safety and Immunogenicity of HS-20090-2 Injection and Prolia® in Healthy Adults

Postmenopausal Osteoporosis

China
Organon and Co

Completed

A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211) (FACT)

Postmenopausal Osteoporosis
Gedeon Richter Plc.

Completed

Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

Poland, United States, Spain, Hungary, Italy, Czechia, Bulgaria, Ukraine
Fresenius Kabi SwissBioSim GmbH

Completed

A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

Hungary, Poland, Georgia, Bulgaria, Czechia, Estonia
Amgen

Completed

An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women (STRUCTURE)

Postmenopausal Osteoporosis

Canada, Belgium, United States, Czechia, Denmark, Poland, Hungary, Spain, Colombia, United Kingdom, Argentina
Organon and Co

Completed

A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)

Postmenopausal Osteoporosis
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults

Postmenopausal Osteoporosis

China
424 General Military Hospital
Leiden University Medical Center; 251 Hellenic Air Force & VA General Hospital

Completed

Zoledronic Acid to Maintain Bone Mass After Denosumab Discontinuation (AfterDmab)

Postmenopausal Osteoporosis

Greece
Amgen

Completed

A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

United States, Poland, Czechia
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Unknown

G56W1 in Women With Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

China
Amgen

Completed

Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis

Postmenopausal Osteoporosis

Germany, Belgium, Austria, Greece

3

Subscribe